HNGE Stock Analysis: Buy, Sell, or Hold?
HNGE - Hinge Health, Inc.
$38.49
-0.07 (-0.18%)
▼
5d:
-4.23%
30d:
-13.23%
90d:
-16.74%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
HNGE is down 14.7% this week, but smart money is accumulating calls. Top strike: $50 2026-06-18 with 699 OI. Call ratio: 94% View Scanner →
Strength: 10.0/10
Get Alerted When HNGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HNGE trading at deep discount. Market pricing in -28.8% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: HNGE trading at deep discount. Market pricing in -28.8% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$94.04
Based on 10.4% avg growth
INTRINSIC VALUE TODAY
$58.39
34.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HNGE is currently trading at $38.49, which is considered oversold relative to its 30-day fair value range of $40.22 to $45.35. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.7) compared to its historical average (46.3). Remarkably, the market is currently pricing in an annual earnings decline of 28.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HNGE is in a downtrend. Immediate support is located at $35.40, while resistance sits at $45.21.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $58.25 (+51.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HNGE is in a downtrend. Immediate support is located at $35.40, while resistance sits at $45.21.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $58.25 (+51.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$40.22 -
$45.35
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 51.3% below Wall St target ($58.25)
Fair Price Analysis
30-Day Fair Range
$40.22 -
$45.35
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$35.40
Resistance Level
$45.21
Current Trend
Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.71
Wall Street Target
$58.25
(+51.3%)
Revenue Growth (YoY)
45.6%
Earnings Growth (YoY)
-80.8%
Profit Margin
-89.9%
Valuation Discount vs History
-28.8% cheaper
PE vs Historical
16.7 vs 46.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-28.8%
(market-implied from PE analysis)
1-Year Target
$34.64
(-10%)
2-Year Target
$31.18
(-19%)
3-Year Target
$28.06
(-27%)
3-Yr Target (if PE normalizes)
(PE: 17→46)
$77.74
(+102%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 16.8%)
$82.03
(+113%)
Base:
(SPY PE: 16.7, Growth: 16.8%)
$61.33
(+59%)
Bear:
(PE: 14.2, Growth: 16.8%)
$52.13
(+35%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.7 to 46.3
Stabilization Target:
$106.64
(+177.1%)
PE Expansion Potential:
+177.1%
Share & Embed Analysis
Last updated: April 02, 2026 6:16 AM ET
Data refreshes hourly during market hours. Next update: 7:16 AM
Data refreshes hourly during market hours. Next update: 7:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HNGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Gabriel M.I. Mecklenburg
SELL
166666 shares
2026-03-06
Daniel Antonio Perez
SELL
166665 shares
2026-02-12
Daniel Antonio Perez
SELL
166665 shares
2026-01-05
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 61 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 66 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 53 HOLD |
Advanced HNGE Option Strategies
Professional options setups generated by AI based on today's HNGE price and gamma walls.